Enlivex Announces 1-for-15 Reverse Split to Avoid Nasdaq Delisting
ENLV is trading near its 52-week low of $0.509 (7.7% below the low).
Summary
Enlivex Ltd. announced a 1-for-15 reverse stock split, effective July 9th. This action is a direct response to the Nasdaq delisting notice the company received on May 15th for failing to meet the minimum $1.00 bid price requirement. The reverse split is a critical step for the company to regain compliance and maintain its listing on Nasdaq. While necessary for compliance, reverse stock splits are generally viewed negatively by the market as they often signal underlying financial weakness and can lead to further stock price volatility.
At the time of this announcement, ENLV was trading at $0.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $123.4M. The 52-week trading range was $0.51 to $2.10. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.